Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Escalon Medical Corp. (ESMC : OTC)
 
 • Company Description   
Escalon Medical Corp. develops, markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices. The company utilizes strategic partnerships to help finance its development programs and is also seeking acquisitions to further diversify its product line to achieve critical mass in sales and take better advantage of the company's distribution capabilities.

Number of Employees: 40

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.32 Daily Weekly Monthly
20 Day Moving Average: 1,560 shares
Shares Outstanding: 7.42 (millions)
Market Capitalization: $2.40 (millions)
Beta: 0.37
52 Week High: $0.46
52 Week Low: $0.11
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -18.05% -21.43%
12 Week 63.49% 43.26%
Year To Date 157.93% 143.61%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
435 Devon Park Drive Suite 824
-
WAYNE,PA 19087
USA
ph: 610-688-6830
fax: 610-688-3641
info@escalonmed.com http://www.escalonmedical.com
 
 • General Corporate Information   
Officers
Richard J. DePiano - Chief Executive Officer and Chairman
Mark Wallace - Chief Operating Officer and Principal Financial &
John P. Dogum - Director
Lisa Napolitano - Director
C. Todd Trusk - Director

Peer Information
Escalon Medical Corp. (ITRJ)
Escalon Medical Corp. (BRLI.)
Escalon Medical Corp. (GOGY)
Escalon Medical Corp. (PSTX.)
Escalon Medical Corp. (ELGXQ)
Escalon Medical Corp. (CAH)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED/DENTAL-SUPP
Sector: Medical
CUSIP: 296074305
SIC: 3845
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 09/29/25
Share - Related Items
Shares Outstanding: 7.42
Most Recent Split Date: 11.00 (0.25:1)
Beta: 0.37
Market Capitalization: $2.40 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 09/29/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 6.47
PEG Ratio: -
Price Ratios
Price/Book: 1.45
Price/Cash Flow: 8.98
Price / Sales: 0.19
EPS Growth
vs. Year Ago Period: 200.00%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 28.86%
vs. Previous Quarter: 7.85%
ROE
06/30/25 - -
03/31/25 - 45.60
12/31/24 - 14.79
ROA
06/30/25 - -
03/31/25 - 12.66
12/31/24 - 3.75
Current Ratio
06/30/25 - -
03/31/25 - 1.92
12/31/24 - 1.95
Quick Ratio
06/30/25 - -
03/31/25 - 1.23
12/31/24 - 1.17
Operating Margin
06/30/25 - -
03/31/25 - 4.69
12/31/24 - 1.43
Net Margin
06/30/25 - -
03/31/25 - 4.70
12/31/24 - 1.43
Pre-Tax Margin
06/30/25 - -
03/31/25 - 4.78
12/31/24 - 1.53
Book Value
06/30/25 - -
03/31/25 - 0.22
12/31/24 - 0.19
Inventory Turnover
06/30/25 - -
03/31/25 - 4.12
12/31/24 - 3.91
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.14
12/31/24 - 0.18
Debt-to-Capital
06/30/25 - -
03/31/25 - 9.18
12/31/24 - 10.76
 

Powered by Zacks Investment Research ©